Quang X. Pham - 23 Jan 2025 Form 4/A - Amendment Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Signature
/s/ Matthew K. Szot, Attorney-in-fact
Issuer symbol
CVKD
Transactions as of
23 Jan 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
24 Mar 2025, 20:38:14 UTC
Date Of Original Report
24 Jan 2025
Previous filing
10 Apr 2024
Next filing
29 Aug 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock Options Award $0 +65,000 $0.000000 65,000 23 Jan 2025 Common Stock 65,000 $19.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment to Form 4 is being filed to correct the exercise price and the expiration date of the stock option, which were incorrectly reported on the original Form 4 filed by the Reporting Person on January 24, 2025 (the "Original Form 4"). The exercise price of the stock option is equal to 100% of the fair market value of the Issuer's common stock on the effective date of the grant and the stock option expires ten years from the date of issuance. The stock option vests according to the vesting schedule as previously reported on the Original Form 4.